DrugBank ID: db00177
DrugCentral: valsartan
Synonymous :(s)-n-valeryl-n-{[2’-(1h-tetrazol-5-yl)biphenyl-4-yl]-methyl}-valine | n-(p-(o-1h-tetrazol-5-ylphenyl)benzyl)-n-valeryl-l-valine | n-pentanoyl-n-{[2’-(1h-tetrazol-5-yl)biphenyl-4-yl]methyl}-l-valine | valsartan

Drug Sentece Context

Table 1. Analysis of context sentence of valsartan gene in 2 abstracts.

pmid sentence
32512291 The primary aim is to investigate the effect of the ARB valsartan compared to placebo on the composite end point of admission to an intensive care unit, mechanical ventilation, or death within 14 days of randomization. […] The active-treatment arm will receive valsartan in a dosage titrated to blood pressure up to a maximum of 160 mg bid, and the placebo arm will receive matching placebo. […] SUMMARY: The PRAETORIAN-COVID trial is a double-blind, placebo-controlled 1:1 randomized trial to assess the effect of valsartan compared to placebo on the occurrence of ICU admission, mechanical ventilation, and death in hospitalized SARS-CoV-2-infected patients.
32532948 A 71-year old gentleman with history of arterial hypertension treated with valsartan presented on was hospitalized at the Infectious Diseases Unit, University of Bologna (Italy) for severe acute respiratory syndrome- coronavirus-2 (SARS-CoV-2) and received treatment with hydroxychloroquine 200mg bid (400 mg bid the first day), azithromycin 400 mg qd, thrombotic prophylaxis with enoxaparin 4000 UI qd and Venturi mask oxygen delivering FiO2 of 31%.